Cargando…

Erythropoietin in the intensive care unit: beyond treatment of anemia

Erythropoietin (EPO) is the major hormone stimulating the production and differentiation of red blood cells. EPO is used widely for treating anemia of critical illness or anemia induced by chemotherapy. EPO at pharmacological doses is used in this setting to raise hemoglobin levels (by preventing th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Nimesh SA, Collino, Massimo, Yaqoob, Muhammad M, Thiemermann, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224459/ https://www.ncbi.nlm.nih.gov/pubmed/21943500 http://dx.doi.org/10.1186/2110-5820-1-40

Ejemplares similares

Bench-to-bedside review: Erythropoietin and its derivatives as therapies in critical care
por: Patel, Nimesh SA, et al.
Publicado: (2012)

Erythropoietin attenuates cardiac dysfunction in experimental sepsis in mice via activation of the β-common receptor
por: Khan, Areeg I., et al.
Publicado: (2013)

Pharmacological preconditioning with erythropoietin attenuates the organ injury and dysfunction induced in a rat model of hemorrhagic shock
por: Nandra, Kiran K., et al.
Publicado: (2013)

Treatment of Anemia in Kidney Disease: Beyond Erythropoietin
por: Wish, Jay B.
Publicado: (2021)

Inhibition of IκB kinase reduces the multiple organ dysfunction caused by sepsis in the mouse
por: Coldewey, Sina M., et al.
Publicado: (2013)

Burden of Anemia in Chronic Kidney Disease: Beyond Erythropoietin
por: Hanna, Ramy M., et al.
Publicado: (2020)

Dopexamine can attenuate the inflammatory response and protect against organ injury in the absence of significant effects on hemodynamics or regional microvascular flow
por: Bangash, Mansoor N, et al.
Publicado: (2013)

Gender Dimorphism of the Cardiac Dysfunction in Murine Sepsis: Signalling Mechanisms and Age-Dependency
por: Chen, Jianmin, et al.
Publicado: (2014)

‘Preconditioning’ with Low Dose Lipopolysaccharide Aggravates the Organ Injury / Dysfunction Caused by Hemorrhagic Shock in Rats
por: Sordi, Regina, et al.
Publicado: (2015)

Beneficial effects of erythropoietin in preclinical models of shock and organ failure
por: Thiemermann, Christoph
Publicado: (2007)

Science review: Recombinant human erythropoietin in critical illness: a role beyond anemia?
por: Coleman, Thomas, et al.
Publicado: (2004)

Inhibition of IκB Kinase at 24 Hours After Acute Kidney Injury Improves Recovery of Renal Function and Attenuates Fibrosis
por: Johnson, Florence L., et al.
Publicado: (2017)

Pathophysiology of intensive care unit-acquired anemia
por: Fink, Mitchell P
Publicado: (2004)

Erythropoietin in Brain Development and Beyond
por: Alnaeeli, Mawadda, et al.
Publicado: (2012)

Linagliptin Attenuates the Cardiac Dysfunction Associated With Experimental Sepsis in Mice With Pre-existing Type 2 Diabetes by Inhibiting NF-κB
por: Al Zoubi, Sura, et al.
Publicado: (2018)

Cost-effectiveness of continuous erythropoietin receptor activator in anemia
por: Schmid, Holger
Publicado: (2014)

Renal Cell Protection of Erythropoietin beyond Correcting The Anemia in Chronic Kidney Disease Patients
por: Nasri, Hamid
Publicado: (2014)

The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders
por: Benetti, Elisa, et al.
Publicado: (2013)

The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities
por: McCafferty, Kieran, et al.
Publicado: (2014)

Anemia and blood transfusion in the critically ill patient: role of erythropoietin
por: Corwin, Howard L
Publicado: (2004)

Erythropoietin stimulating agents in the management of anemia of chronic kidney disease
por: Hayat, Amir, et al.
Publicado: (2008)

Anaemia at discharge from the intensive care unit is associated with an inappropriate erythropoietin response
por: Bateman, A, et al.
Publicado: (2005)

Erythropoietin in the critically ill: do we ask the right questions?
por: McCook, Oscar, et al.
Publicado: (2012)

Nanomedicines in the treatment of anemia in renal disease: focus on CERA (Continuous Erythropoietin Receptor Activator)
por: Panchapakesan, Usha, et al.
Publicado: (2007)

Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity
por: Saeidi, R, et al.
Publicado: (2012)

The hidden role of NLRP3 inflammasome in obesity‐related COVID‐19 exacerbations: Lessons for drug repurposing
por: Bertocchi, Ilaria, et al.
Publicado: (2020)

Lessons learned from peginesatide in the treatment of anemia associated with chronic kidney disease in patients on dialysis
por: Kaushik, Tarun, et al.
Publicado: (2013)

Expanding intensive care medicine beyond the intensive care unit
por: Hillman, Ken
Publicado: (2004)

Erythropoietin and Cancer: The Unintended Consequences of Anemia Correction
por: Debeljak, Nataša, et al.
Publicado: (2014)

Prolyl hydroxylase inhibitor desidustat improves anemia in erythropoietin hyporesponsive state
por: Joharapurkar, Amit A., et al.
Publicado: (2022)

Anemia and blood transfusion and outcome on the intensive care unit
por: Müller, Marcella CA, et al.
Publicado: (2010)

Cardiovascular Complications of Obstructive Sleep Apnea in the Intensive Care Unit and Beyond
por: Wahab, Abdul, et al.
Publicado: (2022)

Examining the Relationship between Cost and Quality of Care in the Neonatal Intensive Care Unit and Beyond
por: Culbertson, Lauren, et al.
Publicado: (2020)

Advancements in nanomedicines for the detection and treatment of diabetic kidney disease
por: Tillman, Luke, et al.
Publicado: (2022)

Erythropoietin Levels in Elderly Patients with Anemia of Unknown Etiology
por: Gowanlock, Zachary, et al.
Publicado: (2016)

Erythropoietin in bone homeostasis—Implications for efficacious anemia therapy
por: Lappin, Katrina M., et al.
Publicado: (2021)

Serum Erythropoietin level in anemia of elderly with unclear etiology
por: Seong, Ju Yong, et al.
Publicado: (2023)

Neonatal hypertension: concerns within and beyond the neonatal intensive care unit
por: Altemose, Kathleen, et al.
Publicado: (2022)

From Anemia to Erythropoietin Resistance in Head and Neck Squamous Cell Carcinoma Treatment: A Carousel Driven by Hypoxia
por: Lazzari, Grazia, et al.
Publicado: (2020)

Anemia and blood transfusion in a surgical intensive care unit
por: Sakr, Yasser, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_lmvd4fn5vgsgpi12ja9tsqu152